Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Glycerophosphodiesterase GDE2 Promotes Neuroblastoma Differentiation through Glypican Release and Is a Marker of Clinical Outcome.
Matas-Rico E, van Veen M, Leyton-Puig D, van den Berg J, Koster J, Kedziora KM, Molenaar B, Weerts MJ, de Rink I, Medema RH, Giepmans BN, Perrakis A, Jalink K, Versteeg R, Moolenaar WH. Matas-Rico E, et al. Among authors: van den berg j, van veen m. Cancer Cell. 2016 Oct 10;30(4):548-562. doi: 10.1016/j.ccell.2016.08.016. Epub 2016 Sep 29. Cancer Cell. 2016. PMID: 27693046 Free article.
Neuronal differentiation through GPI-anchor cleavage.
Matas-Rico E, van Veen M, Moolenaar WH. Matas-Rico E, et al. Among authors: van veen m. Cell Cycle. 2017 Mar 4;16(5):388-389. doi: 10.1080/15384101.2016.1259894. Epub 2016 Nov 18. Cell Cycle. 2017. PMID: 27860541 Free PMC article. No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 34005148
GDE2/GDPD5 in neuroblastoma.
Matas-Rico E, van Veen M, Moolenaar WH. Matas-Rico E, et al. Among authors: van veen m. Oncotarget. 2017 Jan 24;8(4):5672-5673. doi: 10.18632/oncotarget.14233. Oncotarget. 2017. PMID: 28030823 Free PMC article. No abstract available.
Glycerophosphodiesterase GDE2 Promotes Neuroblastoma Differentiation through Glypican Release and Is a Marker of Clinical Outcome.
Matas-Rico E, van Veen M, Leyton-Puig D, van den Berg J, Koster J, Kedziora KM, Molenaar B, Weerts MJA, de Rink I, Medema RH, Giepmans BNG, Perrakis A, Jalink K, Versteeg R, Moolenaar WH. Matas-Rico E, et al. Among authors: van den berg j, van veen m. Cancer Cell. 2016 Dec 12;30(6):986. doi: 10.1016/j.ccell.2016.11.008. Cancer Cell. 2016. PMID: 27960089 Free article. No abstract available.
181 results